Paper32223935
TRK inhibitors in TRK fusion-positive cancers.
Drilon A. Ann Oncol, 2019. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. TRK inhibitors in TRK fusion-positive cancers. Papers, record 32223935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32223935
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Oncogene Proteins, Fusion | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Receptor, trkA | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Humans | |
| Molecular Targeted Therapy |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42539561 | TRK immunohistochemistry in pediatric rhabdomyosarcomas: diagnostic and prognostic utility and limitations. | Pathol Oncol Res | 2026 | https://conductscience.org/library/papers/42539561 | PubMed |
| 42151502 | Targeting fusion proteins in solid tumors: from oncogenic mechanisms to clinical interventions. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42151502 | PubMed |
| 41502888 | Successful treatment of pediatric scalp mesenchymal tumor with NTRK rearrangement: a case report. | Transl Pediatr | 2025 | https://conductscience.org/library/papers/41502888 | PubMed |
| 41301083 | Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301083 | PubMed |
| 40990633 | Molecular advances in early-stage and locally advanced non-small cell lung carcinoma: Shaping the future of precision oncology-systematic review. | Sci Prog | 2025 | https://conductscience.org/library/papers/40990633 | PubMed |
| 40666929 | Development of PROTACs for targeted degradation of oncogenic TRK fusions. | bioRxiv | 2025 | https://conductscience.org/library/papers/40666929 | PubMed |
| 40385986 | RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-of-care setting. | Front Genet | 2025 | https://conductscience.org/library/papers/40385986 | PubMed |
| 39639242 | NTRK fusion promotes tumor migration and invasion through epithelial-mesenchymal transition and closely interacts with ECM1 and NOVA1. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39639242 | PubMed |
| 39366294 | Evolving therapeutic landscape of advanced biliary tract cancer: from chemotherapy to molecular targets. | ESMO Open | 2024 | https://conductscience.org/library/papers/39366294 | PubMed |
| 39326005 | A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis. | Oncologist | 2025 | https://conductscience.org/library/papers/39326005 | PubMed |
| 39014476 | NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/39014476 | PubMed |
| 38938274 | Basket Trials: Past, Present, and Future. | Annu Rev Cancer Biol | 2024 | https://conductscience.org/library/papers/38938274 | PubMed |
| 38791513 | Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791513 | PubMed |
| 38662171 | SEOM-GEINO clinical guidelines for grade 2 gliomas (2023). | Clin Transl Oncol | 2024 | https://conductscience.org/library/papers/38662171 | PubMed |
| 38359439 | Advances in targeted therapy of cholangiocarcinoma. | Ann Med | 2024 | https://conductscience.org/library/papers/38359439 | PubMed |
| 38329731 | Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland. | Oncotarget | 2024 | https://conductscience.org/library/papers/38329731 | PubMed |
| 38322338 | Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38322338 | PubMed |
| 37900189 | The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit. | Ocul Oncol Pathol | 2023 | https://conductscience.org/library/papers/37900189 | PubMed |
| 37707537 | INTEGRATE-Circ and INTEGRATE-Vis: unbiased detection and visualization of fusion-derived circular RNA. | Bioinformatics | 2023 | https://conductscience.org/library/papers/37707537 | PubMed |
| 37385995 | Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37385995 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| NTRK1 | 4914 | PubTator's text mining | https://conductscience.org/library/genes/4914 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32223935
GET https://conductscience.org/api/papers/v1/32223935/cited_by?page=2